Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FAKQX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,050
Award facts
- Contract value 100% obligated
- $29,050.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $29,050.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL syringes on January 28, 2026, with a completion date of January 29, 2026. This non-set-aside award was made through open competition and represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s significantly larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. That IDC, valued at $999,999,999.00 and extending through December 2031, serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and various medical devices.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement. Under its parent company's IDC with DLA, the contractor supplies essential pharmaceutical commodities across multiple therapeutic domains to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The award of Dupixent—a specialty immunology medication—reflects AmerisourceBergen's established capability to fulfill government contracts for brand-name pharmaceutical products required by the Defense Health Agency and other military healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FAKQX?
SPE2DR26FAKQX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FAKQX worth?
The government has obligated $29,050 on SPE2DR26FAKQX.
Is contract SPE2DR26FAKQX an order under another contract?
Yes. SPE2DR26FAKQX is a delivery order under SPE2DR25D1201, an indefinite delivery contract.
Was contract SPE2DR26FAKQX competed?
The extent of competition for SPE2DR26FAKQX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award